Skip to main content
SpringerLink
Log in

Diagnostic Value of Pericardial Fluid Analyses

  • Chapter
Interventional Pericardiology

  • 894 Accesses

Abstract

Pericardial effusion is the result of an increased production and/or decreased clearance of pericardial fluid. Samples of the fluid can be obtained for analyses by either needle pericardiocentesis, catheter drainage or surgical pericardiectomy. While laboratory analyses of pleural effusion are well established, the diagnostic approach to pericardial fluid is less clearly defined. An etiologically correct diagnosis of pericardial diseases can often be based on a positive fluid analysis alone but the sensitivity may vary between 24–93%, depending on the patient cohort and the diagnostic methods [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Meyers DG, Meyers RE, Prendergast TW. The usefulness of diagnostic tests on pericardial fluid. Chest 1997; 111: 1213–1221

    PubMed  CAS  Google Scholar 

  2. Spodick DH. Diagnostic interpretation of pericardial fluids. Chest 1997; 111: 1156–1157

    PubMed  CAS  Google Scholar 

  3. Kjeldsberg CR, Knight JA (eds) Body fluids. 3rd edition. American Society of Clinical Pathologists Press, Chicago, 1993, pp. 159–254

    Google Scholar 

  4. Wiener HG, Kristensen IB, Haubek A, Kristensen B, Baandrup U. The diagnostic value of pericardial cytology. An analysis of 95 cases. Acta Citol 1991; 35(2): 149–153

    CAS  Google Scholar 

  5. King DT, Nieberg RK. The use of cytology to evaluate pericardial effusions. Ann Clin Lab Sci 1979; 9: 8–23

    Google Scholar 

  6. Meyers DG, Boyska DJ. Diagnostic usefulness of pericardial fluid cytology. Chest 1989; 95: 1142–1143

    PubMed  CAS  Google Scholar 

  7. Malamou-Mitsi VD, Zioga AP, Agnantis NJ. Diagnostic accuracy of pericardial fluid cytology: an analysis of 53 specimens from 44 consecutive patients. Diagn Cytopathol 1996; 15(3): 197–204

    PubMed  CAS  Google Scholar 

  8. Garcia LW, Ducatman BS, Wang HH. The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 1994; 7(6): 665–668

    PubMed  CAS  Google Scholar 

  9. Krikorian JG, Hancock EW. Pericardiocentesis. Am J Med 1978; 65: 808–814

    PubMed  CAS  Google Scholar 

  10. Corey GR, Campbell PT, Van Trigt P, et al. Etiology of large pericardial effusions. Am J Med 1993; 95: 209–213

    PubMed  CAS  Google Scholar 

  11. Maisch B, Bethge C, Drude L, Hufnagel G, Herzum M, Schönian U. Pericardioscopy and epicardial biopsy – new diagnostic tools in pericardial and perimyocardial disease. Eur Heart J 1994; 15(Suppl C): 68–73

    PubMed  Google Scholar 

  12. Reyes CV, Strinden C, Banerji M. The role of cytology in neoplastic tamponade. Acta Cytol 1981; 26: 299–302

    Google Scholar 

  13. Theologides A. Neoplastic cardiac tamponade. Semin Oncol 1978; 5: 181–192

    PubMed  CAS  Google Scholar 

  14. Johnson WD. The cytological diagnosis of cancer in serous effusions. Acta Cytol 1966; 10: 161–172

    PubMed  CAS  Google Scholar 

  15. Posner WR, Cohen GI, Skarin AT. Pericardial disease in patients with cancer: the differential diagnosis of malignant from idiopathic and radiation-induced pericarditis. Am J Med 1981; 71: 407–413

    PubMed  CAS  Google Scholar 

  16. Decker DA, Dines DE, Payne WS, et al. The significance of a cytologically negative pleural effusion in bronchogenic carcinoma. Chest 1978; 74: 640–642

    PubMed  CAS  Google Scholar 

  17. Bardales RH, Stanley MW, Schaefer RF, Liblit RL, Owens RB, Surhland MJ. Secondary pericardial malignancies: a critical appraisal of the role of cytology, pericardial biopsy, and DNA ploidy analysis. Am J Clin Pathol 1996;106(1): 29–34.

    Google Scholar 

  18. Maisch B, Ristić AD. Practical aspects of the management of pericardial disease. Heart 2003; 89: 1096–1103

    PubMed  Google Scholar 

  19. Wilkes JD, Fidias P, Vaickus L, Perez RP. Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute. Cancer 1995; 76(8): 1377–1387

    PubMed  CAS  Google Scholar 

  20. Chen CJ, Chang SC, Tseng HH. Assessment of immunocytochemical and histochemical stainings in the distinction between reactive mesothelial cells and adenocarcinoma cells in body effusions. Chung Hua Hsueh Tsa Chih Taipei 1994; 54(3): 49–55

    Google Scholar 

  21. Chen LM, Chao TY, Chiang JH, et al. Examination of pericardial effusions by cytology and immunocytochemistry. Chung Hua Hsueh Tsa Chih Taipei 1996; 58(4): 248–253

    CAS  Google Scholar 

  22. Fischler DF, Wongbunnate S, Johnston DA, Katz RL. DNA content by image analysis. An accurate discriminator of malignancy in pericardial effusions. Anal Quant Cytol Histol 1994; 16(3): 167–173

    PubMed  CAS  Google Scholar 

  23. Rijken A, Dekker A, Taylor S, Hoffman P, Blank M, Krause JR. Diagnostic value of DNA analysis in effusions by flow cytometry and image analysis. A prospective study on 102 patients as compared with cytologic examination. Am J Clin Pathol 1991; 95(1): 6–12

    PubMed  CAS  Google Scholar 

  24. Zakowski MF, Lanuale S, Shanerman A. Cytology of pericardial effusions in AIDS patients. Diagn Cytopathol 1993; 9(3): 266–269

    PubMed  CAS  Google Scholar 

  25. Edoute Y, Kuten A, Ben Haim SA, Moscovitz M, Malberger E. Symptomatic pericardial effusion in breast cancer patients: the role of fluid cytology. J Surg Oncol 1990; 45(4): 265–269

    PubMed  CAS  Google Scholar 

  26. Edoute Y, Malberger E, Kuten A, Moscovitcz M, Ben Haim SA. Symptomatic pericardial effusion in lung cancer patients: the role of fluid cytology. J Surg Oncol 1990; 45(2): 121–123

    PubMed  CAS  Google Scholar 

  27. Edoute Y, Malberger E, Kuten A, Ben Haim SA, Moscovitz M. Cytologic analysis of pericardial effusion complicating extracardiac malignancy. Am J Cardiol 1992; 69(5): 568–571

    PubMed  CAS  Google Scholar 

  28. Wang PC, Yang KY, Chao JY, Liu JM, Perng RP, Yen SH. Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer. Chest 2000; 118: 744–749

    PubMed  CAS  Google Scholar 

  29. Thurber DL, Edwards JE, Achor RWP. Secondary malignant tumors of the pericardium. Circulation 1962; 26: 228–241

    PubMed  CAS  Google Scholar 

  30. Johnson WD. The cytological diagnosis of cancer in serous effusions. Acta Cytol 1966; 10: 161–172

    PubMed  CAS  Google Scholar 

  31. Sahn SA. Malignant pleural effusion. Semin Respir Med 1987; 9: 43–53

    Google Scholar 

  32. Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 1977; 63: 695–702

    PubMed  CAS  Google Scholar 

  33. Fowler NO. Tuberculous pericarditis. JAMA 1991; 266: 99–103

    PubMed  CAS  Google Scholar 

  34. Burgess LJ, Reuter H, Taljaard JJ, Doubell AF. Role of biochemical tests in the diagnosis of large pericardial effusions. Chest 2002; 121(2): 495–499

    PubMed  CAS  Google Scholar 

  35. Paramothayan NS, Barron J. New criteria for the differentiation between transudates and exudates. J Clin Pathol 2002; 55: 69–71

    PubMed  CAS  Google Scholar 

  36. Cegielski JP, Devlin BH, Morris AJ, et al. Comparison of PCR, culture and histopathology for the diagnosis of tuberculous pericarditis. J Clin Microbiol 1997; 35: 3254–3257

    PubMed  CAS  Google Scholar 

  37. Light RW, MacGregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77: 507–513

    PubMed  CAS  Google Scholar 

  38. Light RW. Diagnostic principles in pleural disease. Eur Respir J 1997; 10: 476–481

    PubMed  CAS  Google Scholar 

  39. Jay SJ. Diagnostic procedures for pleural diseases: symposium on pleural diseases. Clin Chest Med 1985; 6: 33–48

    PubMed  CAS  Google Scholar 

  40. Roth BJ, O’Meara TF, Cragun WH. The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest 1990; 98: 546–549

    PubMed  CAS  Google Scholar 

  41. Hamm H, Brohan U, Bohmer R, et al. Cholesterol in pleural effusions: a diagnostic aid. Chest 1987; 92: 296–302

    PubMed  CAS  Google Scholar 

  42. Pillay VKG. Total proteins in serous fluids in cardiac failure. S Afr Med J 1965; 39: 142–143

    PubMed  CAS  Google Scholar 

  43. Chakko SC, Caldwell SH, Sforza PP. Treatment of congestive heart failure: its effect on pleural fluid chemistry. Chest 1989; 95: 978–982

    Google Scholar 

  44. Chakko S. Pleural effusion in congestive heart failure. Chest 1990; 95: 521–522

    Google Scholar 

  45. Pankuweit S, Wadlich A, Meyer E, Portig I, Hufnagel G, Maisch B. Cytokine activation in pericardial fluids in different forms of pericarditis. Herz 2000; 25(8): 748–754

    PubMed  CAS  Google Scholar 

  46. Afanasyeva M, Georgakopoulos D, Fairweather D, Caturegli P, Kass DA, Rose NR. Novel model of constrictive pericarditis associated with autoimmune heart disease in interferon gamma-knockout mice. Circulation 2004; 110: 2910–2917

    PubMed  CAS  Google Scholar 

  47. Ristić AD, Pankuweit S, Meyer E, et al. Proinflammatory and immunoregulatory cytokines in neoplastic, autoreactive, and viral pericarditis. Eur Heart J 2004; 25(Suppl.): P673

    Google Scholar 

  48. Riemann D, Wollert HG, Menschikowski J, Mittenzwei S, Langner J. Immunophenotype of lymphocytes in pericardial fluid from patients with different forms of heart disease. Int Arch Allergy Immunol 1994; 104(1): 48–56

    PubMed  CAS  Google Scholar 

  49. Vila LM, Rivera del Rio JR, Rios Z, Rivera E. Lymphocyte populations and cytokine concentrations in pericardial fluid from a systemic lupus erythematosus patient with cardiac tamponade. Ann Rheum Dis 1999; 58(11): 720–721

    PubMed  CAS  Google Scholar 

  50. Shikama N, Terano T, Hirai A. A case of rheumatoid pericarditis with high concentrations of interleukin-6 in pericardial fluid. Heart 2000; 83(6): 711–712

    PubMed  CAS  Google Scholar 

  51. Abe Y, Muta K, Kato S, et al. A high serum level of interleukin-6 in a patient with aggressive multiple myeloma. Rinsho Ketsueki 1991; 32(11): 1458–1462

    PubMed  CAS  Google Scholar 

  52. Takahashi R, Ashihara E, Hirata T, et al. Aggressive myeloma with subcutaneous tumor and pericardial involvement. Rinsho Ketsueki 1994; 35(3): 291–295

    PubMed  CAS  Google Scholar 

  53. Burgess LJ, Reuter H, Carstens ME, Taljaard JJF, Doubell AF. The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest 2002; 122: 900–905

    PubMed  CAS  Google Scholar 

  54. Mistchenko AS, Maffey AF, Casal G, Kajon AE. Adenoviral pericarditis: high levels of interleukin 6 in pericardial fluid. Pediatr Infect Dis J 1995; 14(11): 1007–1009

    PubMed  CAS  Google Scholar 

  55. Nakayama R, Yoneyama T, Takatani O, Kimura K. A study of metastatic tumors to the heart, pericardium and great vessels. Jpn Heart J 1966; 7: 227–234

    PubMed  CAS  Google Scholar 

  56. Dore P, Lelievre E, Morel F, et al. IL-6 and soluble IL-6 receptors (sIL-6R and sgp130) in human pleural effusions: massive IL-6 production independently of underlying diseases. Clin Exp Immunol 1997; 107(1): 182–188

    PubMed  CAS  Google Scholar 

  57. Hoheisel G, Izbicki G, Roth M, et al. Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Respiration 1998; 65(3): 183–186

    PubMed  CAS  Google Scholar 

  58. Nakano T, Chahinian AP, Shinjo M, et al. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer 1998; 77(6): 907–912

    PubMed  CAS  Google Scholar 

  59. Zhang GJ, Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 1999; 19(2B): 1427–1423

    PubMed  CAS  Google Scholar 

  60. Yokoyama A, Maruyama M, Ito M, Kohno N, Hiwada K, Yano S. Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity. Chest 1992; 102(4): 1055–1059

    PubMed  CAS  Google Scholar 

  61. Marie C, Losser MR, Fitting C, Kermarrec N, Payen D, Cavaillon JM. Cytokines and soluble cytokine receptors in pleural effusions from septic and nonseptic patients. Am J Respir Crit Care Med 1997; 156(5): 1515–1522

    PubMed  CAS  Google Scholar 

  62. Weissflog D, Kroegel C, Luttmann W, Grahmann PR, Hasse J. Leukocyte infiltration and secretion of cytokines in pleural drainage fluid after thoracic surgery: impaired cytokine response in malignancy and postoperative complications. Chest 1999; 115(6): 1604–1610

    PubMed  CAS  Google Scholar 

  63. De Pablo A, Villena V, Echave-Sustaeta J, Encuentra AL. Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis? Chest 1997; 112(5): 1293–1297

    PubMed  Google Scholar 

  64. Hua CC, Chang LC, Chen YC, Chang SC. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions. Chest 1999; 116(5): 1292–1296

    PubMed  CAS  Google Scholar 

  65. Maeda J, Ueki N, Ohkawa T, et al. Transforming growth factor-beta 1 (TGF-beta 1)- and beta 2-like activities in malignant pleural effusions caused by malignant mesothelioma or primary lung cancer. Clin Exp Immunol 1994; 98(2): 319–322

    PubMed  CAS  Google Scholar 

  66. Ikubo A, Morisaki T, Katano M, et al. A possible role of TGF-beta in the formation of malignant effusions. Clin Immunol Immunopathol 1995; 77(1): 27–32

    PubMed  CAS  Google Scholar 

  67. Van Der Weyden MB, Kelley WN. Human adenosine deaminase distribution and properties. J Biol Chem 1976; 251: 5448–5456

    PubMed  Google Scholar 

  68. Bovornkitti S, Pushpakom R, Maranetra N, et al. Adenosine deaminase and lymphocytic populations. Chest 1991; 99: 789–790

    PubMed  CAS  Google Scholar 

  69. Ocaña I, Martinez-Vazquez JM, Segura RM, et al. Adenosine deaminase in pleural fluids: test for diagnosis of tuberculous pleural effusion. Chest 1983; 84: 51–53

    PubMed  Google Scholar 

  70. Burgess LJ, Maritz FJ, Le Roux I, et al. Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy. Thorax 1995; 50: 672–674

    PubMed  CAS  Google Scholar 

  71. Koh KK, Kim EJ, Cho CH, et al. Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. Circulation 1994; 89: 2728–2735

    PubMed  CAS  Google Scholar 

  72. Komsuoglu B, Goldeli O, Kulan K, Komsuoglu SS. The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis. Eur Heart J 1995; 16(8): 1126–1130

    PubMed  CAS  Google Scholar 

  73. Telenti M, Fdez J, Susano R, et al. Tuberculous pericarditis: diagnostic value of adenosine deaminase. Presse Med 1991; 20: 637–640

    PubMed  CAS  Google Scholar 

  74. Martinez-Vazquez JM, Ribera E, Ocaña I, et al. Adenosine deaminase activity in tuberculous pericarditis. Thorax 1986; 41: 888–889

    PubMed  CAS  Google Scholar 

  75. Aggeli C, Pitsavos C, Brili S, et al. Relevance of adenosine deaminase and lysozyme measurements in the diagnosis of tuberculous pericarditis. Cardiology 2000; 94: 81–85

    PubMed  CAS  Google Scholar 

  76. Dogan R, Demircin M, Sarigul A, et al. Diagnostic value of adenosine deaminase activity in pericardial fluids. J Cardiovasc Surg 1999; 40: 501–504

    CAS  Google Scholar 

  77. Maisch B, Seferovic PM, Ristic AD, et al. The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Guidelines on the diagnosis and management of pericardial diseases (executive summary). Eur Heart J 2004; 25: 587–610

    PubMed  Google Scholar 

  78. Arroyo M, Soberman JE. Anenosine deaminase in the diagnosis of tuberculous pericardial effusion. Am J Med Sci 2008; 335(3): 227–229

    PubMed  Google Scholar 

  79. Campbell PT, Li JS, Wall TC, O’Connor CM, et al. Cytomegalovirus pericarditis: a case series and review of the literature. Am J Med Sci 1995; 309(4): 229–234

    PubMed  CAS  Google Scholar 

  80. Rolston KV. Group G streptococcal infections. Arch Intern Med 1986; 146: 857–858

    PubMed  CAS  Google Scholar 

  81. Lam K, Bayer AS. Serious infections due to group G streptococci. Am J Med 1983; 75: 561–570

    PubMed  CAS  Google Scholar 

  82. Fujita NK, Lam K, Bayer AS. Septic arthritis due to group G streptococcus. JAMA 1982; 247: 812–813

    PubMed  CAS  Google Scholar 

  83. Rubin RH, Moellering RC Jr. Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am J Med 1975; 59: 68–78

    PubMed  CAS  Google Scholar 

  84. Klacsmann PG, Bulkley BH, Hutchins GM. The changed spectrum of purulent pericarditis: an 86 year autopsy experience in 200 patients. Am J Med 1977; 63: 666–673

    PubMed  CAS  Google Scholar 

  85. Sagrista-Sauleda J, Barrabes JA, Permanyer-Miralda G, Soler-Soler J. Purulent pericarditis: review of a 20-year experience in a general hospital. J Am Coll Cardiol 1993; 22: 1661–1665

    PubMed  CAS  Google Scholar 

  86. Ricardo Z, Manuel A, Francisco T, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol 1995; 75: 378–382

    Google Scholar 

  87. Gould K, Barnett JA, Sanford JP. Purulent pericarditis in the antibiotic era. Arch Intern Med 1974; 134: 923–927

    PubMed  CAS  Google Scholar 

  88. Klacsmann PG, Bulkley BH, Hutchins GM. The changed spectrum of purulent pericarditis. Am J Med 1975; 59: 68–78

    Google Scholar 

  89. Ilan Y, Oren R, Ben-Chetrit E. Acute pericarditis: Etiology, treatment and prognosis. Jpn Heart J 1991; 32: 315–321

    PubMed  CAS  Google Scholar 

  90. Soler-Soler J, Permanyer-Miralda G, Sagrista-Sauleda J. A systematic diagnostic approach to primary acute pericardial disease: The Barcelona experience. Cardiol Clin 1990; 8: 609–620

    PubMed  CAS  Google Scholar 

  91. Connolly DC, Burchell HB. Pericarditis: A 10-year survey. Am J Cardiol 1961; 7: 7–14

    Google Scholar 

  92. Brook I, Frazier EH. Microbiology of acute purulent pericarditis. A 12-year experience in a military hospital. Arch Intern Med 1996; 156: 1857–1860

    PubMed  CAS  Google Scholar 

  93. Skiest DJ, Steiner D, Werner M, Gamer JG. Anaerobic pericarditis: Case report and review. Clin Infect Dis 1994; 19: 435–440

    PubMed  CAS  Google Scholar 

  94. Aikat S, Ghaffari S. A review of pericardial diseases: Clinical, ECG and hemodynamic features and management. Cleve Clin J Med 2000; 67: 903–914

    PubMed  CAS  Google Scholar 

  95. Kim NH, Park JP, Jeon SH, et al. Purulent pericarditis caused by group G streptococcus as an initial presentation of colon cancer. J Korean Med Sci 2002; 17(4): 571–573

    PubMed  Google Scholar 

  96. Kennedy C, McEvoy S. Purulent pericarditis. Ir J Med Sci 2009; 178: 97–99

    PubMed  CAS  Google Scholar 

  97. Mayosi BM, Wiysonge CS, Ntsekhe M, et al. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J 2008; 98(1): 36–40

    PubMed  Google Scholar 

  98. Lee JH, Lee CW, Lee SG, et al. Comparison of polymerase chain reaction with adenosine deaminase activity in pericardial fluid for the diagnosis of tuberculous pericarditis. Am J Med 2002; 113: 519–521

    PubMed  CAS  Google Scholar 

  99. Piersimoni C, Scarparo C. Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples. J Clin Microbiol 2003; 41: 5355–5365

    PubMed  CAS  Google Scholar 

  100. Seino Y, Ikeda U, Kawaguchi K, et al. Tuberculous pericarditis presumably diagnosed by polymerase chain reaction analysis. Am Heart J 1993; 126: 249–251

    PubMed  CAS  Google Scholar 

  101. Sagrista-Sauleda J, Permanyer-Miralda G, Soler-Soler J. Tuberculous pericarditis: ten-year experience with a prospective protocol for diagnosis and treatment. J Am Coll Cardiol 1988; 11: 724–728

    PubMed  CAS  Google Scholar 

  102. Roberts GD, Goodman NL, Heifets L, et al. Evaluation of the BACTEC radiometric method for recovery of mycobacterium tuberculosis from acid-fast smear-positive specimens. J Clin Microbiol 1983; 18(3): 689–696

    PubMed  CAS  Google Scholar 

  103. Strang JI. Rapid resolution of tuberculous pericardial effusions with high dose prednisone and anti-tuberculous drugs. J Infect 1994; 28(3): 251–254

    PubMed  CAS  Google Scholar 

  104. Horsburgh CR Jr, Feldman S, Ridzon R. Infectious Diseases Society of America. Practice guidelines for the treatment of tuberculosis. Clin Infect Dis 2000; 31(3): 633–639

    PubMed  Google Scholar 

  105. Mayosi BM, Burgess LJ, Doubell AF. Tuberculous pericarditis. Circulation 2005; 112(23): 3608–3616

    PubMed  Google Scholar 

  106. Harmon WG, Dadlani GH, Fisher SD, Lipshultz SE. Myocardial and pericardial disease in HIV. Curr Treat Options Cardiovasc Med 2002; 4(6): 497–509

    PubMed  Google Scholar 

  107. Goodman LJ. Purulent pericarditis. Curr Treat Options Cardiovasc Med 2000; 2(4): 343–350

    PubMed  Google Scholar 

  108. Estok L, Wallach F. Cardiac tamponade in a patient with AIDS: a review of pericardial disease in patients with HIV infection. Mt Sinai J Med 1998; 65(1): 33–39

    PubMed  CAS  Google Scholar 

  109. DeCastro S, Migliau G, Silvestri A, et al. Heart involvement in AIDS: a prospective study during various stages of the disease. Eur Heart J 1992; 13: 1452–1459

    CAS  Google Scholar 

  110. Nathan PE, Arsura EL, Zappi M. Pericarditis with tamponade due to cytomegalovirus and the acquired immunodeficiency syndrome. Chest 1991; 99: 765–766

    PubMed  CAS  Google Scholar 

  111. Toma E, Poisson M, Claessens MR, et al. Herpes simplex type 2 pericarditis and bilateral facial palsy in patients with AIDS. J Infect Dis 1989; 160: 553–554

    PubMed  CAS  Google Scholar 

  112. Chen Y, Brennessel D, Walters J, et al. Human immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of literature. Am Heart J 1999; 137: 516–521

    PubMed  CAS  Google Scholar 

  113. Fink L, Reicheck N, Sutton MG. Cardiac abnormalities in acquired immune deficiency syndrome. Am J Cardiol 1984; 54: 1161–1163

    PubMed  CAS  Google Scholar 

  114. Silva-Cardoso J, Moura B, Martins L, et al. Pericardial involvement in human immunodeficiency virus infection. Chest 1999; 115: 418–422

    PubMed  CAS  Google Scholar 

  115. Onorato IM, McCray E. Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States. J Infect Dis 1992; 165(1): 87–92

    PubMed  CAS  Google Scholar 

  116. Centers for Disease Control and Prevention. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. MMWR Morb Mortal Wkly Rep 1998; 47(RR-20): 1–51

    Google Scholar 

  117. Wells CD, Cegielski JP, Nelson LJ, et al. HIV infection and multidrug-resistant tuberculosis: the perfect storm. J Infect Dis 2007; 196 (Suppl 1): S86–107

    PubMed  Google Scholar 

  118. Evans DJ. The use of adjunctive corticosteroids in the treatment of pericardial, pleural and meningeal tuberculosis: do they improve outcome? Respir Med 2008; 102(6): 793–800

    PubMed  CAS  Google Scholar 

  119. Syed FF, Mayosi BM. A modern approach to tuberculous pericarditis. Prog Cardiovasc Dis 2007; 50(3): 218–236

    PubMed  Google Scholar 

  120. San José NE, Alvarez D, Valdés L, et al. Utility of tumour markers in the diagnosis of neoplastic pleural effusion. Clin Chim Acta 1997; 265: 193–205

    PubMed  Google Scholar 

  121. Hanley KZ, Facik MS, Bourne PA, et al. Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions. Cancer 2008; 114(1): 49–56

    PubMed  CAS  Google Scholar 

  122. Szturmowicz M, Tomkowski W, Fijalkowska A, et al. Diagnostic utility of CYFRA 21–1 and CEA assays in pericardial fluid for the recognition of neoplastic pericarditis. Int J Biol Markers 2005; 20(1): 43–49

    PubMed  CAS  Google Scholar 

  123. Kjeldsberg CR, Knight JA, editors. Body fluids. 3rd edition. American Society of Clinical Pathologists Press, Chicago, 1993, pp 159–254

    Google Scholar 

  124. Conejo JR, Benedito JE, Jiminez A, et al. Diagnostic value of three tumor markers determined in pleural effusions. Eur J Clin Chem Biochem 1996; 34: 139–142

    CAS  Google Scholar 

  125. Niwa Y, Kishimoto H, Shimokata K. Carcinomatous and tuberculous pleural effusions; comparison of tumour markers. Chest 1985; 87: 351–355

    PubMed  CAS  Google Scholar 

  126. Mezger J, Permanetter W, Gerbes AL, et al. Tumour-associated antigens in diagnosis of serous effusions. J Clin Pathol 1988; 41: 633–643

    PubMed  CAS  Google Scholar 

  127. Salama G, Miedouge M, Rouzard P, et al. Evaluation of pleural CYFRA 21–1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions. Br J Cancer 1998; 77: 472–476

    PubMed  CAS  Google Scholar 

  128. Lee YC, Knox BS, Garrett JE. Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21–1) in the differentiation of malignant and benign pleural effusions. Aust N Z J Med 1999; 29: 765–769

    PubMed  CAS  Google Scholar 

  129. Koh KK, In HH, Lee KH, et al. New scoring system using tumour markers in diagnosing patients with moderate pericardial effusions. Int J Cardiol 1997; 61: 5–13

    PubMed  CAS  Google Scholar 

  130. Tatsuta M, Yamamura H, Yamamoto R, et al. Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis. Oncology 1984; 41: 328–330

    PubMed  CAS  Google Scholar 

  131. Szturmowicz M, Tomkowski W, Fijalkowska A, et al. The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis. Int J Biol Markers 1997; 12: 96–101

    PubMed  CAS  Google Scholar 

  132. Seo T, Ikeda Y, Onaka H et al. Usefulness of serum CA125 measurement for monitoring pericardial effusion. Jpn Circ J 1993; 57(6): 489–494

    PubMed  CAS  Google Scholar 

  133. Yücel AE, Calguneri M, Ruacan S. False positive pleural biopsy and high CA125 levels in serum and pleural effusion in systemic lupus erythematosus. Clin Rheumatol 1996; 15(3): 295–297

    PubMed  Google Scholar 

  134. Roy N, Blurton DJ, Azakie A, Karl TR. Immature intrapericardial teratoma in a newborn with elevated alpha-fetoprotein. Ann Thorac Surg 2004; 78(1): e6–8

    PubMed  Google Scholar 

  135. Carachi R, Campbell PE, Chow CW, Mee BB. Alpha-fetoprotein-(AFP-)-secreting intra-pericardial teratoma – report of a case diagnosed on CT scanning. Z Kinderchir 1986; 41(6): 369–370

    PubMed  CAS  Google Scholar 

  136. Upadhyaya M, Jaffar Sajwany M, Tomas-Smigura E. Recurrent immature mediastinal teratoma with life-threatening respiratory distress in a neonate. Eur J Pediatr Surg 2003; 13(6): 403–406

    PubMed  CAS  Google Scholar 

  137. Calick A, Bishop R. Pericardial effusion in rheumatoid arthritis. Chest 1973; 64: 778–779

    PubMed  CAS  Google Scholar 

  138. Dogan R, Demircin M, Sarigul A, Ciliv G, Bozer AY. Diagnostic value of adenosine deaminase activity in pericardial fluids. J Cardiovasc Surg (Torino) 1896; 40: 501–504

    Google Scholar 

  139. Godfrey-Faussett P, Wilkins EG, Khoo S, Stoker N. Tuberculous pericarditis confirmed by DNA amplification. Lancet 1991; 337: 176–177

    PubMed  CAS  Google Scholar 

  140. Shikama N, Terano T, Hirai A. A case of rheumatoid pericarditis with high concentrations of interleukin-6 in pericardial fluid. Heart 2000; 83(6): 711–712

    PubMed  CAS  Google Scholar 

  141. Thadani U, Iveson JM, Wright V. Cardiac tamponade, constrictive pericarditis and pericardial resection in rheumatoid arthritis. Medicine (Baltimore) 1975; 54: 261–270

    Google Scholar 

  142. Leventhal LJ, DeMarco DM, Zurier RB. Antinuclear antibody in pericardial fluid from a patient with primary cardiac lymphoma. Arch Intern Med 1990; 150: 1113–1115

    PubMed  CAS  Google Scholar 

  143. Ng TT, Strang JI, Wilkins EG. Serodiagnosis of pericardial tuberculosis. Q J Med 1995; 88: 317–320

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine – Cardiology, Philipps University Marburg, Marburg, Germany

    Bernhard Maisch MD, FESC, FACC (Professor of Internal Medicine – Cardiology, Director)

  2. Department of Cardiology, Institute of Cardiovascular Diseases, Clinical Center of Serbia, Belgrade University School of Medicine, Belgrade, Serbia

    Arsen D. Ristić MD, PhD, FESC (Associate Professor of Internal Medicine – Cardiology)

  3. Department of Cardiology Clinical Center of Serbia, Belgrade University School of Medicine, Belgrade, Serbia

    Petar M. Seferović MD, PhD, FESC, FACC (Professor of Internal Medicine – Cardiology)

  4. Diamond Health Care Centre, University of British Columbia, 2775 Laurel Street, BC V5Z 1M9, Vancouver, Canada

    Teresa S. M. Tsang MD, FACC (Professor of Medicine)

Authors
  1. Bernhard Maisch MD, FESC, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arsen D. Ristić MD, PhD, FESC
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Petar M. Seferović MD, PhD, FESC, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Teresa S. M. Tsang MD, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Maisch, B., Ristić, A.D., Seferović, P.M., Tsang, T.S.M. (2011). Diagnostic Value of Pericardial Fluid Analyses. In: Interventional Pericardiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11335-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11335-2_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11334-5

  • Online ISBN: 978-3-642-11335-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation